GLP-3 (RT)
A 39-amino acid triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, studied for metabolic regulation and body composition in clinical research. Premium Research Peptide.
Price range: $69.99 through $199.99
Verified Test Results
Every batch, independently verified.
Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory. The report below reflects the identity, purity and full-panel specification data released with this product.
Certificate of Analysis
Purity by HPLC
| Parameter | Result | Specification |
|---|---|---|
| Appearance | Good | Meets spec |
| Purity | 99.86% · Pass | ≥ 95% |
| Net Peptide Content | 10.4mg | Report |
| Identity | Confirmed | Meets spec |
| Fentanyl Screen | Not Detected | Pass |
| Heavy Metals | Not Detected | Pass |
| Sterility | No Growth | Pass |
| Endotoxin | < 0.05 EU/mL | Reported |
Representative report from lot RT0004 (GLP-3 (RT)). Your order ships with its own lot-specific certificate.
View this batch's certificateThird-party verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch's certificate below.
Compound Information
Technical specifications
What Is GLP-3 (RT)?
Stability Information
Sources & References
Peer-reviewed research
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
Jastreboff AM, et al.
GLP-3 (RT) for People with Type 2 Diabetes — A Phase 2 Trial
Rosenstock J, et al.
GLP-3 (RT) for Metabolic Dysfunction-Associated Steatotic Liver Disease
Sanyal AJ, et al.
Effects of GLP-3 (RT) on Body Composition
Coskun T, et al.
Triple Agonism Based Therapies for Obesity
GLP-3 (RT) — A Game Changer in Obesity Pharmacotherapy
Efficacy and Safety of GLP-3 (RT) — Systematic Review & Meta-Analysis
TRIUMPH-4 Phase 3 Trial Results
Structural Analysis of Incretin Receptor Agonists
GLP-3 (RT) Compound Information
GLP-3 (RT) Clinical Trials Registry
Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
Frequently asked questions
A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.
Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.
A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.
Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.